Suboxone is not considered dangerous to the heart for most people. The FDA prescribing label carries no cardiovascular boxed warnings or contraindications, and the active ingredient buprenorphine has a dramatically wider safety margin for heart rhythm disruption than methadone, the other major medication used to treat opioid use disorder. That said, Suboxone does have some measurable effects on heart rhythm and blood pressure worth understanding, especially if you already have cardiac risk factors.
Heart Rhythm and QT Prolongation
The biggest cardiac concern with any opioid medication is QT prolongation, a delay in the heart’s electrical recovery cycle that can, in rare cases, trigger dangerous irregular rhythms. Suboxone does cause a small amount of QT prolongation, up to about 15 milliseconds in clinical studies. That’s a modest change. For context, the threshold regulators consider worrisome is around 10 milliseconds, so buprenorphine sits close to that line but not dramatically above it.
What matters more is how buprenorphine compares to methadone, since many people weighing Suboxone are also considering methadone. The difference is stark. Methadone directly blocks a specific potassium channel in heart cells (called hERG) that plays a central role in dangerous rhythm problems, and it has a safety margin of only about 6 times above the concentration that starts interfering with that channel. Buprenorphine’s safety margin for the same channel is over 10,000. A 2020 study in PLOS ONE confirmed that at the concentrations actually found in the blood during treatment, buprenorphine and its main metabolite do not meaningfully block any of the key cardiac ion channels. Methadone, by comparison, inhibits several of them. No documented cases of the dangerous rhythm called torsades de pointes have been linked to buprenorphine in the medical literature, while methadone carries a well-established risk.
The FDA label still recommends caution if you have certain pre-existing conditions: low potassium or magnesium levels, a slow heart rate, congestive heart failure, a history of atrial fibrillation, or a baseline prolonged QT interval. If any of those apply, your prescriber may want to monitor your heart more closely, but Suboxone is not contraindicated.
Blood Pressure Effects
Like other opioids, Suboxone can cause orthostatic hypotension, a temporary drop in blood pressure when you stand up. This can cause dizziness or lightheadedness, particularly when you first start the medication or after a dose increase. It’s generally mild and tends to improve as your body adjusts. Staying hydrated and standing up slowly can help. This effect is not unique to Suboxone and is common across the opioid class.
Heart Rate and the Nervous System
Research from the University of North Carolina found that buprenorphine measurably increases heart rate and reduces heart rate variability, at least in pregnant women with opioid use disorder. Heart rate variability is a marker of how flexibly your nervous system responds to changing demands, and lower variability is generally considered less ideal for cardiovascular health. These changes occurred regardless of the buprenorphine dose and were observed at multiple points during pregnancy.
Whether this finding extends to non-pregnant adults on long-term Suboxone therapy is less clear, but it suggests buprenorphine does shift the balance of the autonomic nervous system, slightly favoring the “fight or flight” side over the calming side. For most people, this shift is not clinically dangerous, but it’s worth noting if you already have a condition where elevated resting heart rate is a concern.
Long-Term Heart Attack Risk
A study presented through the American Heart Association looked at over 61,000 people, including 539 on buprenorphine, to see whether the medication increased the risk of heart attacks over time. At first glance, buprenorphine users did appear to have slightly higher heart attack risk. But once researchers accounted for the fact that those users already had more diabetes, high blood pressure, kidney disease, and other cardiovascular risk factors going in, the elevated risk disappeared entirely. The adjusted hazard ratio dropped to 0.92, meaning buprenorphine itself was not independently raising heart attack risk.
This is an important distinction. People who end up on Suboxone often have health histories shaped by years of substance use, inconsistent medical care, smoking, and other factors that independently raise cardiovascular risk. The medication does not appear to add to that burden.
How Suboxone Can Protect the Heart
One of the most serious cardiac threats facing people who inject opioids is infective endocarditis, a bacterial infection of the heart valves that can be fatal. This risk comes not from the opioid itself but from non-sterile injection practices. The American Heart Association has stated that medications like buprenorphine and methadone reduce all-cause mortality by more than 50% in people with opioid use disorder. They do this partly by reducing or eliminating injection drug use, which in turn lowers the risk of heart valve infections.
For someone choosing between continued illicit opioid use and Suboxone treatment, the cardiac math is not close. The infection, overdose, and cardiovascular risks of ongoing injection drug use far outweigh the modest, manageable cardiac effects of buprenorphine. Patients who stay engaged in addiction treatment after an episode of endocarditis have the best long-term outcomes.
How Suboxone Compares to Methadone
Overall mortality during treatment is low for both medications. One large comparison found death rates of 0.13% for methadone and 0.08% for buprenorphine, a difference that was not statistically meaningful. But the cardiac safety profiles are different in kind, not just degree. Methadone directly interferes with cardiac ion channels at therapeutic doses. Buprenorphine does not. If you or your prescriber have specific concerns about heart rhythm, buprenorphine-based medications like Suboxone are generally the safer choice between the two.
For the average person taking Suboxone as prescribed, the medication poses no serious threat to heart health. The small QT effect, the mild blood pressure changes, and the slight heart rate increase are real but manageable, and they are vastly outweighed by the protective effects of stable treatment for opioid use disorder.